In our investigation of the immunological microenvironment in gastric cancer (GC) patients, we observed strong correlations between CLDN18.2 expression levels and CD4 + T cells, CD8 + T cells, and B cells according to the TISIDB database analysis (Figure S2A, all p < 0.05). Here, CLDN18 is linked to gastric cancer.